Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA.
Am Heart J. 2010 Aug;160(2):209-14. doi: 10.1016/j.ahj.2010.05.020.
In acute heart failure syndrome (AHFS), dyspnea is one of the most common but least understood presenting symptoms for hospitalization. For this reason, dyspnea relief is increasingly becoming a focus in the development of therapies for the treatment of AHFS, and currently stands as an acceptable primary end point for regulatory approval by governmental agencies. This raises the question of how best to measure such a subjective symptom. In this review, we will describe the basis for dyspnea, provide a detailed description of the strengths and weaknesses of the current best tools used to measure it, and describe future directions for future development of dyspnea measurement in AHFS.
在急性心力衰竭综合征(AHFS)中,呼吸困难是最常见但也是最不被理解的住院症状之一。出于这个原因,呼吸困难的缓解在 AHFS 治疗方法的开发中越来越成为一个关注焦点,并且目前已经成为政府机构监管批准的可接受的主要终点。这就提出了一个问题,即如何最好地衡量这种主观症状。在这篇综述中,我们将描述呼吸困难的基础,详细描述目前用于测量呼吸困难的最佳工具的优缺点,并描述未来在 AHFS 中开发呼吸困难测量方法的未来方向。